Scinovex
articleTop 1% cited

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly

Archives of Neurology · 2008 · Vol. 65(11) · pp. 1509–1509
Howard AizensteinRobert D. NebesJudith SaxtonJulie C. PriceChester A. MathisNicholas D. TsopelasScott K. ZiolkoJeffrey A. JamesBeth E. SnitzPatricia R. HouckWenzhu BiAnn D. CohenBrian J. LoprestiSteven T. DeKoskyEdythe M. HalliganWilliam E. Klunk

Abstract

Amyloid deposition can be identified among cognitively normal elderly persons during life, and the prevalence of asymptomatic amyloid deposition may be similar to that of symptomatic amyloid deposition. In this group of participants without clinically significant impairment, amyloid deposition was not associated with worse cognitive function, suggesting that an elderly person with a significant amyloid burden can remain cognitively normal. However, this finding is based on relatively small numbers and needs to be replicated in larger cohorts. Longitudinal follow-up of these subjects will be required to support the potential of PiB imaging to identify preclinical Alzheimer disease, or, alternatively, to show that amyloid deposition is not sufficient to cause Alzheimer disease within some specified period.

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAdvanced Neuroimaging Techniques and ApplicationsPittsburgh compound BMedicineCognitionAmyloid (mycology)DementiaAsymptomaticAlzheimer's diseasePopulationPositron emission tomographyInternal medicine

MeSH terms

AgedAged, 80 and overAllelesAmyloidAniline CompoundsBrainCognitionFemaleHeterozygoteHumansMaleNeuropsychological TestsReference ValuesThiazolesPositron-Emission Tomography

Funding

  • U.S. Department of Energy
  • Alzheimer's Association
Citations
1,046
FWCI
35.84
field-weighted impact
References
52
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.